Cargando…
Preventing Cushing: Iatrogenic Cushing Syndrome due to Ritonavir-Fluticasone Interaction
Ritonavir is commonly used in low doses to boost plasma levels of protease inhibitors in patients with human immunodeficiency virus (HIV) infections. It is also a potent inhibitor of cytochrome P450. We present a 50-year-old African American male with past medical history of HIV on highly active ant...
Autores principales: | Tiruneh, Fasil, Awan, Ahmad, Didana, Abiot, Doshi, Saumil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602273/ https://www.ncbi.nlm.nih.gov/pubmed/28944123 http://dx.doi.org/10.7759/cureus.1484 |
Ejemplares similares
-
Iatrogenic Cushing Syndrome and Secondary Adrenal Insufficiency Due to an Interaction Between Fluticasone and Ritonavir
por: Gutiérrez, Lorena Suárez
Publicado: (2021) -
Iatrogenic Cushing syndrome and multifocal osteonecrosis caused by the interaction between inhaled fluticasone and ritonavir
por: Figueiredo, Joana, et al.
Publicado: (2020) -
Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone
por: Epperla, Narendranath, et al.
Publicado: (2015) -
Iatrogenic Cushing’s syndrome with inhaled fluticasone
por: Ledger, Thomas, et al.
Publicado: (2019) -
Avascular Necrosis of Both Hips From Iatrogenic Cushing ’s Syndrome due to Coadministration of Fluticasone and Ritonavir in an HIV-Infected Patient
por: Kant, Ravi, et al.
Publicado: (2020)